• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.47% Nasdaq Up0.39%

    More On ADLS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials


    Advanced Life Sciences Holdings, Inc. (ADLS)

    -Other OTC
    0.02 0.00(0.00%) Apr 17
    Add to Portfolio
    ProfileGet Profile for:
    Advanced Life Sciences Holdings, Inc.
    1440 Davey Road
    Woodridge, IL 60517
    United States - Map
    Phone: 630-739-6744
    Fax: 630-739-6754
    Website: http://www.advancedlifesciences.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:16

    Business Summary 

    Advanced Life Sciences Holdings, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs in the therapeutic areas of infection, oncology, and respiratory disease. The company’s lead product candidate includes Restanza, a once-a-day oral antibiotic for the treatment of respiratory tract infections, including community acquired bacterial pneumonia and biodefense pathogens, such as anthrax, plague, and tularemia. It is also developing ALS-357, a compound for the topical treatment of malignant melanoma; and ALS-886, a therapeutic for the treatment of inflammation-related tissue damage consisting of tissue damage associated with acute respiratory distress syndrome. The company has collaboration agreements with Abbott Laboratories to develop and commercialize cethromycin; University of Illinois to develop, make, use, and sell ALS-357 and related compounds; and Baxter International, Inc. Advanced Life Sciences Holdings, Inc. was founded in 1999 and is headquartered in Woodridge, Illinois.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Advanced Life Sciences Holdings, Inc.

    Key Executives 
     PayExercised
    Dr. Michael T. Flavin Ph.D., 57
    Founder, Chairman and Chief Exec. Officer
    404.00K0.00
    Mr. John L. Flavin , 44
    Pres, Chief Financial Officer, Principal Accounting Officer, Sec. and Director
    328.00K0.00
    Dr. Ze-Qi Xu Ph.D., 53
    Chief Scientific Officer, Exec. VP and Sec. of Advanced Life Sciences Inc
    301.00K0.00
    Mr. Patrick W. Flavin J.D., 40
    Chief Legal Counsel
    N/AN/A
    Dr. Suseelan Pookote Ph.D., 61
    Exec. VP of Corp. Devel.
    N/AN/A
    Amounts are as of Dec 31, 2010 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders